ABSTRACT Macromolecular albumin-IgG complexes have been isolated from human serum and characterized immunologically. These complexes are shown to be present in plasma also and appear to be normal constituents of blood., The complexes can be demonstrated in normal serum and plasma by immunoelectrophoresis and rocket immunoelectrophoresis, as well as by use of a two-step radioimmunologic binding test. The albumin-IgG complexes inhibit adhesion ofhuman platelets to glass and account for 12-16% of the total protein in serum.
Platelets, by virtue of their seemingly innate adhesiveness to many nonbiologic materials used in the fabrication of cardiovascular or other blood-contacting prosthetic or diagnostic devices, appear to play an important role in blood-material interactions (1, 2). Adhesion and aggregation of platelets account for a major part of the thrombocytopenia found with the use of extracorporeal or implanted devices that contact blood. Embolization ofthrombus fragments or platelet aggregates is a recognized hazard inherent in the use of such devices (2) . Increasing clinical application in recent years of prosthetic devices in the cardiovascular and certain other organ systems (3) has induced a number of investigators to develop new artificial surfaces that have enhanced blood compatibility. These clinical developments have also led workers to search for either naturally occurring or synthetic agents that might reduce the adhesion of platelets to artificial surfaces. No single artificial surface yet available has proved to be highly blood compatible, and the ideal antiadhesive agent has not been reported.
One of the major problems in studies of blood-material interactions has been the direct quantitation of platelet adhesion to artificial surfaces in vitro or in vivo. Such quantitative techniques are needed to evaluate meaningfully the compatibility oftest surfaces with blood. Most methods used in the past were either qualitative or measured both adhesion and aggregation (3) . The recent availability of more specific methods (4) (5) (6) has permitted identification of agents that inhibit platelet adhesion to artificial surfaces. Certain prostaglandins (6), 13 -lipoproteins, and a number of other plasma proteins (7, 8) have been found to inhibit platelet adhesion selectively.
In earlier studies, we reported the presence ofplatelet adhesion inhibitory activities in human serum and plasma (8, 9) . Several of these plasma components were purified and characterized, while others were not (8) .
We report here the isolation, identification, and immunologic characterization of naturally occurring complexes of albumin with IgG from human serum and plasma that inhibit platelet adhesion to glass. The albumin-IgG complexes were first isolated from serum. Next, they were shown to be present in untreated plasma and serum. Finally, a general technique for radioimmunologic detection ofthese and possibly other protein-protein complexes in plasma and serum was developed.
MATERIALS AND METHODS Collection and Processing of Blood and Blood Components.
Blood from normal healthy donors of either sex, 20-40 years old, who denied receiving medication of any type for at least 1 week preceding venepuncture was drawn by the two-syringe technique into plastic syringes containing 0.108 M sodium citrate (one part anticoagulant to eight parts blood). Platelet-rich plasma and platelet-poor plasma were prepared as described (8, 9) .
Platelets were isolated from platelet-rich plasma by gel filtration on Sepharose 2B (10 Serum was obtained from human blood drawn without anticoagulant and allowed to clot at 370C for 2 hr. Serum was removed and centrifuged at 3000 x g for 30 min, incubated at 370C for 16 hr, and then passed through a Millipore filter (pore size, 0.8 pum). Incubated filtered sterile serum for the isolation ofplatelet adhesion inhibitory activity and the platelet adhesion test was either used immediately or stored frozen at -70'C.
Determination of Platelet Adhesion. Platelet adhesion to glass was quantitated by an in vitro centrifugation method described previously (5) .
Isolation of the Platelet Adhesion Inhibitory Activity. Human serum was lyophilized and then extracted five times with twice the original volume using chloroform/methanol, 2:1 (voV vol). The isolation method then used consisted of (i) salting out at 50% saturation with neutral ammonium sulfate, (ii) chromatography of the resultant globulin fraction on Affi-Gel Blue (Bio-Rad), and (iii) sequential chromatography of the globulin fraction from Affi-Gel Blue chromatography on Sephadex G-100 and Sepharose 6B. Platelet adhesion inhibitor (PAI) The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. of 10 ml of 10% alum [AIK(SO4)2.12 H20] with 0.25 M NaOH. PAI was added to the alum solution before titration. After 10 min of stirring at 230C, the PAI-alumina precipitate was separated by centrifugation at 500 X g for 10 min and suspended in water to give 10 mg (dry weight) of the precipitate per ml. The PAI-alumina suspension was injected subcutaneously into animals at four sites in the forelimbs and hindlimbs. Injection of antigen was repeated every 15 days for 2 months. In another set of experiments, PAI (100 ,ug) was injected subcutaneously in the skin of the backs of rabbits at multiple sites after prior emulsification with Freund's complete adjuvant. Injections were repeated weekly for 8 weeks.
All animals were bled from the ear vein. Blood was allowed to clot, and sera were stored at 4TC after addition of sodium azide to a final concentration of 0.01%.
Purification of Monospecific Antibodies. IgG fractions of rabbit anti-human albumin (monospecific by immunodiffusion and immunoelectrophoresis, 5.5mg ofantibody protein per ml) were obtained from Cappel Laboratories (Cochranville, PA) and then further purified by affinity chromatography on Sepharose 4B coupled by means ofCNBr with purified albumin according to the manufacturer's instruction (Pharmacia). These preparations will be referred to as monospecific antialbumin.
Goat antiserum against human IgG (y-chain specific) (Antibodies, Inc.) was fractionated by chromatography on DEAEAffi-Gel Blue to obtain the IgG fraction. The IgG fractions of v-chain-specific anti-IgG were then purified by adsorption with (i) glutaraldehyde-polymerized human albumin and (ii) glutaraldehyde-polymerized rabbit anti-human albumin (IgG fraction). The purified anti-IgG thus obtained was monospecific as determined by immunodiffusion and immunoelectrophoresis tests and will be referred to as monospecific anti-IgG.
Radioimmunologic Technique. PAI, fresh and untreated serum, and plasma were treated with excess monospecific antiIgG for 16 hr at 4-60C. The precipitates were centrifuged at 7000 x g for 30 min at 40C and washed three times with 1 ml of Pi/NaCV0. 1% gelatin. The washed precipitates were suspended in 200 1d of PiNaCVgelatin by brief sonication (Ultrasonic Cleaner B52, Smith Kline, New York) and then incubated with 50 ,ul of "I-labeled antialbumin ["I-labeled antialbumin (specific activity, 1300 cpm/ng; 8 mg/ml)/unlabeled antialbumin (1.6 mg/ml), 1:20] in PiNaCVgelatin for 16 hr at 40C. The precipitates were separated by centrifugation at 7000 X g for 30 min and washed three times with 1 ml of PiNaCVgelatin/ 0.2% Tween 20. The radioactivity in each tube was measured in a Beckman Gamma-8000 counter. The counting efficiency for 125I was -83%.
Other Procedures. Protein estimation (11), immunoelectrophoresis in Immuno-AgaroSlides (Millipore Biomedica), rocket immunoelectrophoresis (12) , polymerization of proteins with glutaraldehyde (13) , and iodination ofproteins with Na'25I using chloramine-T (14) were performed by standard procedures.
Materials. Human serum albumin (100% immunologic purity) used in affinity chromatography to purify antialbumin antibodies and in other experiments was from Behring (Somerville, NJ) and will be referred to simply as albumin or as free or noncomplexed albumin. Crystallized human serum albumin used in platelet adhesion tests was obtained from Sigma. Purified human IgG was from Miles and will be referred to simply as IgG or as free or noncomplexed IgG. Both crystallized albumin and purified IgG produced three bands in gradient (2.5-27%) polyacrylamide gel electrophoresis but only one precipitin arc when tested by immunoelectrophoresis with either respective specific antisera or antisera against whole human serum. CNBr-activated Sepharose 4B was from Pharmacia (Uppsala, Sweden). Antisera against whole human serum raised Proc. Natd Acad. Sci. USA 78 (1981) 7751 in rabbits and monospecific antisera against the Fc-fragment of human IgG (2.1 mg of antibody per ml) and human complement-reactive protein raised in goats were from Miles. Specific antisera against other human serum proteins raised in rabbits were obtained from Behring. Agarose (electroendosmosis, relative mobility = 0.13 + 0.02) was from Bio-Rad.
RESULTS AND DISCUSSION
PAI, first detected in human serum and plasma because of its inhibition of platelet adhesion to glass, was isolated from delipidated human serum as described in Materials and Methods. A significant loss of PAI activity occurred at the Affi-Gel Blue chromatography step. PAI activity equal to that in the globulin fraction from Affi-Gel Blue was also present in the fraction retained by the gel. Because Affi-Gel Blue binds albumin and PAI is a complex of albumin and IgG, it may be that the larger portion of PAI activity is lost in the protein fraction that binds to the gel. The protein fraction bound to Affi-Gel Blue is complex, and attempts to purify PAI from this fraction were not successful. Only 10 mg of the PAI preparation was recovered from 100 ml (7 g of protein) of fresh normal human serum by the method described.
The PAI preparation migrates as a single band in the a1-a2-region in microzone electrophoresis. Its elution from Sepharose 6B in the void volume ofthe column indicates that PAI is oflarge molecular size. PAI forms a long single precipitation arc in immunoelectrophoresis with rabbit antisera against either PAI (Fig. 1 A and F) or human serum (Fig. 1E) . The arc lay between those produced by human IgG and albumin. PAI also crossreacted with both monospecific antisera against human albumin and IgG (y-chain-specific and Fc-fragment specific). The PAI preparation did not react with whole rabbit antisera against order in each case. The recovery of PAI was 293% in each instance, assuming binding in the absence of albumin or IgG to be 100%. These observations indicate that appreciable amounts of albumin and IgG are present as macromolecular complexes in both serum and plasma. The findings further show that these albumin-IgG complexes have not been formed during the procedures used to isolate the PAT. It is curious that separate precipitin arcs corresponding to the complex have not been described previously in immunoelectrophoresis of serum when this test is conducted with either antialbumin or anti-IgG antisera. Immunoelectrophoresis of human serum in 1% agarose gels normally produces only one precipitin arc with antialbumin or with anti-IgG. Consequently, electrophoresis was performed using different amounts of serum. Immunoelectrophoretic patterns for four different strengths of normal untreated fresh human serum in Immuno-AgaroSlides with monospecific antialbumin and with monospecific anti-Fc-IgG are shown in Fig. 1 B and C, respectively.
Immunoelectrophoresis of undiluted human serum (2 jA) produced two arcs with antialbumin, one ofthem characteristic ofalbumin; these two arcs were partially identical. Similar studies with anti-IgG produced only one arc (Fig. 1C) . Failure to see a precipitation arc in routine immunoelectrophoresis of serum versus anti-IgG may be due to the following reasons: (i) the arc remains fused with the IgG-anti-IgG arc, (ii) the amount of IgG in the PAI complex is small and does not form a separate visible arc with anti-IgG, or (iii) both of these. To verify these possibilities, electrophoresis of serum was conducted using larger volumes ofserum than are normally loaded. The results (Fig. 1C) (4 g/100 ml) diluted 1:300, 1:200, and 1:100, respectively; 13 and 14, purified human IgG (1 g/100 ml) diluted 1:100; 15 and 16, purified human IgG (1 g/100 ml) diluted 1:10; 9, 10, and 17-19, PAI preparation (2.5 mg/ml) diluted 1:10; 11, 12, 20, and 21, PAI preparation (2.5 mg/ml) diluted 1:0. Each plate contained 1 ml of either monospecific antialbumin or monospecific anti-IgG.
Results are representative examples of five experiments.
as the arc produced by PAI and anti-IgG is weaker and shorter than that produced by PAI and antialbumin, anti-whole serum, or anti-PAT. The latter possibility has not been proven at this time, but these observations suggest that PAI contains less IgG than albumin.
Further immunoelectrophoretic and immunoadsorption studies of PAI preparations were conducted to rule out the possibility that albumin and IgG were present in noncomplexed form. In immunoelectrophoretic studies in 1% agarose, the PAI preparation produced a single long precipitin arc having a mobility between that ofalbumin and IgG when tested with either anti-PAI, monospecific antialbumin, or monospecific anti-IgG (Fig. 1 D and F) ; similar results were obtained in tests with antiserum against whole human serum (Fig. 1E) . In rocket immunoelectrophoretic studies ofPAI preparations (Fig. 3) 
